{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:07:57Z","timestamp":1791446877349,"version":"4.3.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Genetic testing in hypertrophic cardiomyopathy (HCM) is a published guideline-based recommendation. The diagnostic yield of genetic testing and corresponding HCM-associated genes have been largely documented by single center studies and carefully selected patient cohorts. Our goal was to evaluate the diagnostic yield of genetic testing in a heterogeneous cohort of patients with a clinical suspicion of HCM, referred for genetic testing from multiple centers around the world.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective review of patients with a suspected clinical diagnosis of HCM referred for genetic testing at Blueprint Genetics was undertaken. The analysis included syndromic, myopathic and metabolic etiologies. Genetic test results and variant classifications were extracted from the database. Variants classified as pathogenic (P) or likely pathogenic (LP) were considered diagnostic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 1376 samples were analyzed. Three hundred and sixty-nine tests were diagnostic (26.8%); 373 P or LP variants were identified. Only one copy number variant was identified. The majority of diagnostic variants involved genes encoding the sarcomere (85.0%) followed by 4.3% of diagnostic variants identified in the RASopathy genes. Two percent of diagnostic variants were in genes associated with a cardiomyopathy other than HCM or an inherited arrhythmia. Clinical variables that increased the likelihood of identifying a diagnostic variant included: an earlier age at diagnosis (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001), a higher maximum wall thickness (MWT) (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001), a positive family history (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001), the absence of hypertension (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0002), and the presence of an implantable cardioverter-defibrillator (ICD) (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0004).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The diagnostic yield of genetic testing in this heterogeneous cohort of patients with a clinical suspicion of HCM is lower than what has been reported in well-characterized patient cohorts. We report the highest yield of diagnostic variants in the RASopathy genes identified in a laboratory cohort of HCM patients to date. The spectrum of genes implicated in this unselected cohort highlights the importance of pre-and post-test counseling when offering genetic testing to the broad HCM population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-021-01927-5","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T03:03:33Z","timestamp":1614913413000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Diagnostic yield of genetic testing in a heterogeneous cohort of 1376 HCM patients"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0144-4653","authenticated-orcid":false,"given":"Julie","family":"Hathaway","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista","family":"Heli\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inka","family":"Saarinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonna","family":"Tallila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eija H.","family":"Sepp\u00e4l\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sari","family":"Tuupanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannu","family":"Turpeinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiia","family":"Kangas-Kontio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Schleit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Tommiska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ville","family":"Kyt\u00f6l\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miko","family":"Valori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikko","family":"Muona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Sistonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pertteli","family":"Salmenper\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Myllykangas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jussi","family":"Paananen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tero-Pekka","family":"Alastalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiina","family":"Heli\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha","family":"Koskenvuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,5]]},"reference":[{"issue":"39","key":"1927_CR1","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","volume":"35","author":"PM Elliott","year":"2014","unstructured":"Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, et al. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathythe task force for the diagnosis and management of hypertrophic cardiomyopathy of the european society of cardiology (ESC). Eur Heart J. 2014;35(39):2733\u201379.","journal-title":"Eur Heart J"},{"issue":"4","key":"1927_CR2","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","volume":"92","author":"BJ Maron","year":"1995","unstructured":"Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Circulation. 1995;92(4):785\u20139.","journal-title":"Circulation"},{"issue":"12","key":"1927_CR3","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","volume":"65","author":"C Semsarian","year":"2015","unstructured":"Semsarian C, Ingles J, Maron MS, Maron BJ. New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2015;65(12):1249\u201354.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"1927_CR4","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.jacc.2012.02.068","volume":"60","author":"BJ Maron","year":"2012","unstructured":"Maron BJ, Maron MS, Semsarian C. Genetics of hypertrophic cardiomyopathy after 20 years clinical perspectives. J Am Coll Cardiol. 2012;60(8):705\u201315.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1927_CR5","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1034\/j.1399-0004.2003.00151.x","volume":"64","author":"J Erdmann","year":"2003","unstructured":"Erdmann J, Daehmlow S, Wischke S, Senyuva M, Werner U, Raible J, et al. Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy. Clin Genet. 2003;64(4):339\u201349.","journal-title":"Clin Genet"},{"issue":"6","key":"1927_CR6","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S0025-6196(11)61527-9","volume":"80","author":"SLV Driest","year":"2005","unstructured":"Driest SLV, Ommen SR, Tajik AJ, Gersh BJ, Ackerman MJ. Yield of genetic testing in hypertrophic cardiomyopathy. Mayo Clin Proc. 2005;80(6):739\u201344.","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"1927_CR7","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/humu.20862","volume":"30","author":"PS Andersen","year":"2009","unstructured":"Andersen PS, Havndrup O, Hougs L, S\u00f8rensen KM, Jensen M, Larsen LA, et al. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives. Hum Mutat. 2009;30(3):363\u201370.","journal-title":"Hum Mutat"},{"issue":"6","key":"1927_CR8","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.mayocp.2014.01.025","volume":"89","author":"JM Bos","year":"2014","unstructured":"Bos JM, Will ML, Gersh BJ, Kruisselbrink TM, Ommen SR, Ackerman MJ. Characterization of a phenotype-based genetic test prediction score for unrelated patients with hypertrophic cardiomyopathy. Mayo Clin Proc. 2014;89(6):727\u201337.","journal-title":"Mayo Clin Proc"},{"issue":"11","key":"1927_CR9","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/gim.2014.205","volume":"17","author":"AA Alfares","year":"2015","unstructured":"Alfares AA, Kelly MA, McDermott G, Funke BH, Lebo MS, Baxter SB, et al. Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity. Genet Med. 2015;17(11):880\u20138.","journal-title":"Genet Med"},{"issue":"8","key":"1927_CR10","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.3390\/ijms17081239","volume":"17","author":"S Rubattu","year":"2016","unstructured":"Rubattu S, Bozzao C, Pennacchini E, Pagannone E, Musumeci BM, Piane M, et al. A next-generation sequencing approach to identify gene mutations in early- and late-onset hypertrophic cardiomyopathy patients of an italian cohort. Int J Mol Sci. 2016;17(8):1239.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"1927_CR11","doi-asserted-by":"publisher","first-page":"e0181465","DOI":"10.1371\/journal.pone.0181465","volume":"12","author":"I Mademont-Soler","year":"2017","unstructured":"Mademont-Soler I, Mates J, Yotti R, Espinosa MA, P\u00e9rez-Serra A, Fernandez-Avila AI, et al. Additional value of screening for minor genes and copy number variants in hypertrophic cardiomyopathy. PLoS ONE. 2017;12(8):e0181465.","journal-title":"PLoS ONE"},{"issue":"4","key":"1927_CR12","doi-asserted-by":"crossref","first-page":"e001666","DOI":"10.1161\/CIRCGENETICS.116.001666","volume":"10","author":"C Burns","year":"2018","unstructured":"Burns C, Bagnall RD, Lam L, Semsarian C, Ingles J. Multiple gene variants in hypertrophic cardiomyopathy in the era of next-generation sequencing. Circ Cardiovasc Genet. 2018;10(4):e001666.","journal-title":"Circ Cardiovasc Genet"},{"issue":"2","key":"1927_CR13","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s41436-018-0046-0","volume":"21","author":"F Mazzarotto","year":"2019","unstructured":"Mazzarotto F, Girolami F, Boschi B, Barlocco F, Tomberli A, Baldini K, et al. Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single center. Genet Med. 2019;21(2):284\u201392.","journal-title":"Genet Med"},{"issue":"5","key":"1927_CR14","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201323.","journal-title":"Genet Med"},{"issue":"2","key":"1927_CR15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/mgg3.187","volume":"4","author":"O Ceyhan-Birsoy","year":"2016","unstructured":"Ceyhan-Birsoy O, Pugh TJ, Bowser MJ, Hynes E, Frisella AL, Mahanta LM, et al. Next generation sequencing-based copy number analysis reveals low prevalence of deletions and duplications in 46 genes associated with genetic cardiomyopathies. Mol Genet Genom Med. 2016;4(2):143\u201351.","journal-title":"Mol Genet Genom Med"},{"issue":"3\u20134","key":"1927_CR16","first-page":"57","volume":"8","author":"CD Russo","year":"2014","unstructured":"Russo CD, Giacomo GD, Cignini P, Padula F, Mangiafico L, Mesoraca A, et al. Comparative study of aCGH and Next Generation Sequencing (NGS) for chromosomal microdeletion and microduplication screening. J Prenat Med. 2014;8(3\u20134):57\u201369.","journal-title":"J Prenat Med"},{"issue":"7","key":"1927_CR17","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1038\/s41436-018-0375-z","volume":"21","author":"KL Thomson","year":"2019","unstructured":"Thomson KL, Ormondroyd E, Harper AR, Dent T, McGuire K, Baksi J, et al. Analysis of 51 proposed hypertrophic cardiomyopathy genes from genome sequencing data in sarcomere negative cases has negligible diagnostic yield. Genet Med. 2019;21(7):1576\u201384.","journal-title":"Genet Med"},{"issue":"2","key":"1927_CR18","doi-asserted-by":"publisher","first-page":"e002460","DOI":"10.1161\/CIRCGEN.119.002460","volume":"12","author":"J Ingles","year":"2019","unstructured":"Ingles J, Goldstein J, Thaxton C, Caleshu C, Corty EW, Crowley SB, et al. Evaluating the clinical validity of hypertrophic cardiomyopathy genes. Circ Genom Precis Med. 2019;12(2):e002460.","journal-title":"Circ Genom Precis Med"},{"issue":"4","key":"1927_CR19","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/ajmg.a.61072","volume":"179","author":"D Aljeaid","year":"2019","unstructured":"Aljeaid D, Sanchez AI, Wakefield E, Chadwell SE, Moore N, Prada CE, et al. Prevalence of pathogenic and likely pathogenic variants in the RASopathy genes in patients who have had panel testing for cardiomyopathy. Am J Med Genet A. 2019;179(4):608\u201314.","journal-title":"Am J Med Genet A"},{"issue":"7","key":"1927_CR20","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1002\/humu.23535","volume":"39","author":"O Ceyhan-Birsoy","year":"2018","unstructured":"Ceyhan-Birsoy O, Miatkowski MM, Hynes E, Funke BH, Mason-Suares H. NGS testing for cardiomyopathy: utility of adding RASopathy-associated genes. Hum Mutat. 2018;39(7):954\u20138.","journal-title":"Hum Mutat"},{"issue":"5","key":"1927_CR21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ejmg.2010.07.007","volume":"53","author":"G Millat","year":"2010","unstructured":"Millat G, Bouvagnet P, Chevalier P, Dauphin C, Jouk PS, Costa AD, et al. Prevalence and spectrum of mutations in a cohort of 192 unrelated patients with hypertrophic cardiomyopathy. Eur J Med Genet. 2010;53(5):261\u20137.","journal-title":"Eur J Med Genet"},{"issue":"1","key":"1927_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1161\/CIRCGENETICS.112.963363","volume":"6","author":"C Gruner","year":"2013","unstructured":"Gruner C, Ivanov J, Care M, Williams L, Moravsky G, Yang H, et al. Toronto hypertrophic cardiomyopathy genotype score for prediction of a positive genotype in hypertrophic cardiomyopathy. Circ Cardiovasc Genet. 2013;6(1):19\u201326.","journal-title":"Circ Cardiovasc Genet"},{"issue":"5","key":"1927_CR23","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cardfail.2018.03.004","volume":"24","author":"RE Hershberger","year":"2018","unstructured":"Hershberger RE, Givertz M, Ho CY, Judge DP, Kantor P, McBride KL, et al. Genetic evaluation of cardiomyopathy\u2014a heart failure society of america practice guideline. J Card Fail. 2018;24(5):281\u2013302.","journal-title":"J Card Fail"},{"issue":"2","key":"1927_CR24","first-page":"e001620","volume":"10","author":"J Ingles","year":"2017","unstructured":"Ingles J, Burns C, Bagnall RD, Lam L, Yeates L, Sarina T, et al. Nonfamilial hypertrophic cardiomyopathy. Circulation cardiovasc. Genetics. 2017;10(2):e001620.","journal-title":"Genetics"},{"issue":"11","key":"1927_CR25","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/nbt.1996","volume":"29","author":"S Myllykangas","year":"2011","unstructured":"Myllykangas S, Buenrostro JD, Natsoulis G, Bell JM, Ji HP. Efficient targeted resequencing of human germline and cancer genomes by oligonucleotide-selective sequencing. Nat Biotechnol. 2011;29(11):1024\u20137.","journal-title":"Nat Biotechnol"},{"issue":"2","key":"1927_CR26","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/gim.2016.90","volume":"19","author":"R Walsh","year":"2017","unstructured":"Walsh R, Thomson KL, Ware JS, Funke BH, Woodley J, McGuire KJ, et al. Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. Genet Med. 2017;19(2):192\u2013203.","journal-title":"Genet Med"},{"issue":"11","key":"1927_CR27","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1038\/s41588-019-0528-2","volume":"51","author":"AR Martin","year":"2019","unstructured":"Martin AR, Williams E, Foulger RE, Leigh S, Daugherty LC, Niblock O, et al. PanelApp crowdsources expert knowledge to establish consensus diagnostic gene panels. Nat Genet. 2019;51(11):1560\u20135.","journal-title":"Nat Genet"},{"issue":"9","key":"1927_CR28","doi-asserted-by":"publisher","first-page":"e0203422","DOI":"10.1371\/journal.pone.0203422","volume":"13","author":"SUM Vanninen","year":"2018","unstructured":"Vanninen SUM, Leivo K, Sepp\u00e4l\u00e4 EH, Aalto-Set\u00e4l\u00e4 K, Pitk\u00e4nen O, Suursalmi P, et al. Heterozygous junctophilin-2 (JPH2) p.(Thr161Lys) is a monogenic cause for HCM with heart failure. PLoS ONE. 2018;13(9):e0203422.","journal-title":"PLoS ONE"},{"issue":"4","key":"1927_CR29","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jacc.2018.04.078","volume":"72","author":"RD Bagnall","year":"2018","unstructured":"Bagnall RD, Ingles J, Dinger ME, Cowley MJ, Ross SB, Minoche AE, et al. Whole genome sequencing improves outcomes of genetic testing in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2018;72(4):419\u201329.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"1927_CR30","doi-asserted-by":"crossref","first-page":"e001768","DOI":"10.1161\/CIRCGENETICS.117.001768","volume":"10","author":"AL Cirino","year":"2018","unstructured":"Cirino AL, Lakdawala NK, McDonough B, Conner L, Adler D, Weinfeld M, et al. A comparison of whole genome sequencing to multigene panel testing in hypertrophic cardiomyopathy patients. Circ Cardiovasc Genet. 2018;10(5):e001768.","journal-title":"Circ Cardiovasc Genet"},{"issue":"3","key":"1927_CR31","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s12265-014-9542-z","volume":"7","author":"JD Kapplinger","year":"2014","unstructured":"Kapplinger JD, Landstrom AP, Bos JM, Salisbury BA, Callis TE, Ackerman MJ. Distinguishing hypertrophic cardiomyopathy-associated mutations from background genetic noise. J Cardiovasc Transl. 2014;7(3):347\u201361.","journal-title":"J Cardiovasc Transl"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-021-01927-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-021-01927-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-021-01927-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T22:34:20Z","timestamp":1671489260000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-021-01927-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,5]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1927"],"URL":"https:\/\/doi.org\/10.1186\/s12872-021-01927-5","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,5]]},"assertion":[{"value":"24 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Our study has been reviewed by the Western Institutional Review Board (IRB) and received an exemption determination.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Minor conflict of interest: SM, TPA, JK are co-founders of Blueprint Genetics and JH, IS, JT, EHS, ST, TKK, JS, JTo, VK, MV, MM, JSi, MG, PS, SM, JP, TPA, and JK are full-time employees of Blueprint Genetics, which offers genetic diagnostic services.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"126"}}